These results suggested the therapeutic benefit of DC exosomes in Alzheimer’s disease since BACE1 is responsible for the N-terminal cleavage of amyloid precursor protein that produces the aggregate-forming β-amyloid peptide in Alzheimer’s disease pathogenesis (112). The gene discussed is BACE1; the disease is Alzheimer disease.